Lorazepam Reduced Restlessness, Agitation in Cancer Patients With Delirium



(MedPage Today) — Use of lorazepam-based regimens reduced persistent restlessness and agitation associated with end-of-life delirium in cancer patients, a randomized study showed.
Among 72 patients in a palliative care setting, those who received…



Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/116844

Author :

Publish date : 2025-08-05 20:27:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version